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Efficacy and durability of endovascular
thoracoabdominal aortic aneurysm repair using
the caudally directed cuff technique
Linda M. Reilly, MD,a Joseph H. Rapp, MD,b S. Marlene Grenon, MD,b Jade S. Hiramoto, MD,a
Julia Sobel, BS,a and Timothy A. M. Chuter, DM,a San Francisco, Calif
Objective: This study determined early and intermediate results of multibranched endovascular thoracoabdominal
(TAAA) and pararenal aortic aneurysm (PRAA) repair using a uniform operative technique.
Methods: Eighty-one patients (mean age, 73  8 years, 19 [23.5%] women) underwent endovascular TAAA repair in a
prospective trial using self-expanding covered stents connecting axially oriented, caudally directed cuffs to target aortic
branches. Mean aneurysm diameter was 67  10 mm. Thirty-nine TAAA (48.1%) were Crawford type II, III, or V; 42
(51.9%) were type IV or pararenal. Thirty-three procedures (40.7%) were staged. The insertion approach was femoral for
aortic components and brachial for branch components. Follow-up assessments were performed at 1, 6, and 12 months,
and yearly thereafter.
Results:All devices (n 81) and branches (n 306) were successfully inserted and deployed, with no conversions to open
repair. Overall mortality was 6.2% (n  5), including three perioperative (3.7%) and two late treatment-related deaths
(2.5%). Permanent paraplegia occurred in three patients (3.7%), and transient paraplegia/paraparesis occurred in 16
(19.8%). Four patients (4.9%) required dialysis postoperatively, three permanently and one transiently. Women
accounted for 67% of the paraplegia, 75% of the perioperative dialysis, and 60% of the perioperative or treatment-related
deaths. During a mean follow-up of 21.2 months, no aneurysms ruptured, but four (4.9%) enlarged: two were
successfully treated, one was unsuccessfully treated, and one was not treated. No late onset spinal cord ischemia symptoms
developed. Of the five patients starting dialysis during follow-up, two resulted from renal branch occlusion. Sixteen
branches occluded (nine renal, two celiac) or developed stenoses (four renal, one superior mesenteric artery), requiring
stenting. Primary patency was 94.8%, and primary-assisted patency was 95.1%. Thirty-two patients (39.5%) underwent
42 reinterventions. Of 25 early reinterventions (<45 days), 10 were to treat access or insertion complications, and 5 were
for endoleak. Of 17 late reinterventions, eight were for endoleak and five were for branch stenosis/occlusion. New
endoleaks developed in two patients during follow-up. Overall, 73 of 81 patients (90.1%) were treated without
procedure-related death, dialysis, paralysis, aneurysm rupture, or conversion to open repair.
Conclusions: Total endovascular TAAA/PRAA repair using caudally directed cuffs is safe, effective, and durable in the
intermediate term. The most common form of late failure, renal artery occlusion, rarely had a clinically significant
consequence (dialysis). The trend toward worse outcome in women needs further study. (J Vasc Surg 2012;56:53-64.)
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pThe challenge of successfully treating thoracoabdomi-
nal aortic aneurysms (TAAA), defined as preventing rup-
ture with acceptable mortality, morbidity, and durability,
has prompted increased application of endovascular
techniques to treat this pathology. Options for total endo-
vascular treatment of TAAA now include the use of fenes-
trated grafts,1-5 branched grafts,6-20 and snorkel (chimney)
grafts.21
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http://dx.doi.org/10.1016/j.jvs.2012.01.006Although the feasibility of total endovascular TAAA
epair has been demonstrated, technique-specific efficacy
nd durability data remain sparse. Many reports combine
he results of patients treated with fenestrated devices and
hose treated with branched devices,6-10 and many patients
re treated with devices that combine fenestrations and
ranches.8-10,17,20 In addition, the branch structure used
n the treatment of TAAA (caudally directed vs cranially
irected, radial vs spiral vs axial orientation) varies within
nd between reports. As a consequence, assessing the
trengths and weaknesses of each technique and comparing
specific endovascular technique vs conventional open
AAA repair and hybrid TAAA repair remains difficult.
This study reports the early and intermediate results of
uniform endovascular technique—multibranched stent
rafts using caudally directed cuffs—used to treat TAAA
nd pararenal aortic aneurysms (PRAA).
ETHODS
Study design. This single-center, nonrandomized,
rospective clinical trial, was conducted under an investiga-
ional device exemption approved by the Food and Drug
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July 201254 Reilly et alAdministration (FDA) and the University of California at
San Francisco Committee onHuman Research. All patients
were evaluated according to previously published inclusion
and exclusion criteria designed to identify patients at in-
creased risk for open repair because of physiologic or ana-
tomic comorbidities.13 All patients gave informed consent.
After endovascular TAAA/PRAA repair, all patients were
assessed clinically and with imaging at 1, 6, and 12 months,
and then yearly. The mean follow-up interval was 21.4 
17.6 months, and no patient was lost to follow-up. Data on
patient demographics, arterial anatomy, stent graft design,
stent graft implantation, component use, procedural de-
tails, and clinical and radiographic outcomes were collected
prospectively.
Patient population. Between January 2006 and July
2011, 94 patients with TAAA or PRAA underwent endo-
vascular repair using multibranched stent grafts. Thirteen
patients are not included (1 treated under compassionate
use, 12 treated with nonuniform devices and techniques).
The remaining 81 patients (86.2%) form the basis of this
report (Fig 1). All patients were hemodynamically stable,
although two were symptomatic. Twenty-nine screened
patients were excluded for anatomic reasons, most com-
monly related to the iliofemoral access arteries, the renal
arteries, or the visceral arteries.
There were 62 men (76.5%) and 19 women (23.5%)
with a mean age of 73.2 7.8 years. The comorbidity
patient profile was typical of patients with vascular disease
(Table I). At baseline, 27 (33.3%) had abnormal renal
function (serum creatinine 1.4 mg/dL), including two
on dialysis and two about to start dialysis before endovas-
cular TAAA/PRAA repair. The mean baseline creatinine
for the entire group was 1.3 0.9 mg/dL, slightly greater
in patients treated early than in patients treated recently
(Table II). Most aneurysms were atherosclerotic, and max-
imal aneurysm diameter was 67.1  10.1 mm. Thirty-nine
aneurysms (48.1%) were Crawford type II, III, or V, and 42
Fig 1. Clinical experience with total endovascular thoracoab-
dominal/pararenal aortic aneurysm (TAAA/PRAA) repair during
the past 6 years.(51.2%) were Crawford type IV or PRAA. Thirty-eight (atients (46.9%) had previously undergone one or more
ortic operations, most commonly open repair of an infra-
enal aortic aneurysm (Table I).
Devices. All cuffed components were based on the
enith stent graft platform (Cook Australia, Brisbane,
LD, Australia) and generally contained four cuffs, con-
tructed as internal/external cuffs, axially oriented and
audally directed (Fig 2). Fifty devices (61.7%) were cus-
om-made, with cuff position determined by the patient’s
natomy (custom devices), and 31 (38.3%) were con-
tructed using a consistent craniocaudal and circumferen-
ial cuff position (standard devices).15,19 No spiral (direc-
ional) cuffs, cranially directed cuffs, radially directed cuffs,
r fenestrations were used.
Thirty-one patients (38.3%) required additional proxi-
al aortic components, using commercially available Ze-
ith TX2 or Zenith TX2 with Proform endovascular grafts
able I. Patient demographics
ariables Mean  SD or No. (%)
omorbidity
Age, years 73.2  7.8
Gender
Men 62 (76.5)
Women 19 (23.5)
Renal insufficiencya 27 (33.3)
On dialysis 4 (4.9)
Coronary artery disease 39 (48.1)
Prior myocardial infarction 13 (16.0)
Pulmonary disease 29 (35.8)
Requiring medication 16 (19.8)
Tobacco use 71 (87.7)
Current 20 (24.7)
Diabetes 7 (8.6)
IAOD 17 (21.0)
neurysm status
Etiology
Atherosclerosis 77 (95.1)
Dissection 4 (4.9)
Crawford Class
I 0 (0.0)
II 19 (23.5)
III 11 (13.6)
IV 19 (23.5)
V 9 (11.1)
Pararenal 23 (28.4)
Diameter, mm 67.1  10.1
rior aortic operationsb 38 (46.9)
AAA repair
Open 24
Endovascular 2
TAA repair
Open 3
Endovascular 4
Open TAAA repair 4
Ascending aortic aneurysm repair 3
Aortorenal bypass 1
AA, Abdominal aortic aneurysm; IAOD, infrainguinal arterial occlusive
isease; SD, standard deviation; TAA, thoracic aortic aneurysm; TAAA,
horacoabdominal aortic aneurysm.
Creatinine 1.4 mg/dL.
41 operations in 38 patients.Cook Medical Inc, Bloomington, Ind), Gore TAG or
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Volume 56, Number 1 Reilly et al 55Gore C-TAG thoracic endoprostheses (W. L. Gore and
Associates, Flagstaff, Ariz), or custom-made thoracic com-
ponents (Cook Australia), as determined by the aortic
anatomy (proximal neck diameter and length of aorta need-
ing treatment). Sixty-five patients (80.2%) required infrare-
nal extensions: 21 into the infrarenal aorta or body of a
prior aortic graft and 44 into the common iliac arteries, the
iliac limb of a prior aortic graft, or a surgically constructed
conduit. Infrarenal extensions used commercially available
Zenith stent grafts for AAA, the Zenith Renu device (Cook
Medical Inc), or custom-made infrarenal components
(Cook Australia), as determined by the anatomy of the
anticipated distal implantation site and seal zone.
Almost all branch extensions used Fluency covered
stents (CR Bard Inc, Tempe, Ariz), measuring 60 to 80
Table II. Time trends
Variablea All
Age, years 73.2  7.8
Length of stay, days 14.4  17.1
Median 10
Max aneurysm diameter, mm 67.2  10.1
Percent of aorta covered 72.7  16.1
Fluoroscopy time, minutes 130.4  68.5
Contrast volume, mL 137.0  81.6
Operative time, minutes 369.9  121.8
Estimated blood loss, mL 535.4  592.6
Creatinine, mg/dL
Preop 1.31  0.9
Maximum 1.84  1.2
At discharge 1.49  1.0
aAll data are mean  standard deviation unless otherwise stated.
bP  .05, analysis of variance.
Fig 2. Cuffed stent graft demonstrates axial cuffs tmm in length and 6 to 10 mm in diameter. Viabahn (overed stents (6 to 7 mm in diameter and 100 mm in
ength) were used in six patients (seven branches). All
ranch extensions were reinforced with vascular Wallstents
Boston Scientific Corp, Natick, Mass), 6 to 10 mm in
ominal diameter and 36 to 39 mm in nominal length.
Technique. Aortic and aortoiliac components were
nserted through surgically exposed femoral arteries or
reviously constructed iliofemoral conduits (unilateral, 19;
ilateral, 5). Thoracic components were inserted first, fol-
owed by the cuffed component, and finally, by infrarenal or
ortoiliac components, or both. After all aortic components
ere inserted, the primary femoral arterial access site was
epaired and flow restored (usually within 45 to 60 min-
tes) to prevent lengthy limb ischemia. At the conclusion of
he repair, on average 72.7%  16.1% of the aortic length
Patient group
1 2 3
ients 1-27 Patients 28-55 Patients 56-81
 7.1b 73.7  6.5 69.9  8.8b
 10.2 11.9  7.5 11.7  5.5
9 10 11
 9.8 67.6  9.0 66.1  11.6
 16.9 70.9  15.3 75.9  16.0
 52.7 110.1  48.8 145.2  92.6
 84.6b 92.4  32.5b 138.1  90.8
 109.0b 306.6  103.1b 356.7  112.9b
 313.4 423.1  209.4 549.0  696.7
 0.46 1.25  0.39 1.19  0.36
 0.86 1.64  0.85 1.80  1.15
 0.70 1.32  0.62 1.37  0.64
re caudally oriented and half internal-half external.Pat
75.9
19.6
67.3
71.1
136.0
180.4
445.8
630.6
1.51
2.11
1.79measured from the left subclavian artery orifice to the
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July 201256 Reilly et alaortic bifurcation) had been replaced, including the length
of all endovascular stent grafts inserted during this index
procedure plus the length of aorta covered or replaced by
any prior open or endovascular aortic procedure.
Covered stents were inserted into the target branches
through the surgically exposed proximal brachial artery
(left, 73; right, eight) and were lined with supporting
stents. Of 306 inserted branches, 76 were placed into the
celiac axis, 81 into the superior mesenteric artery, 78 into
the right renal artery, 70 into the left renal artery, and one
into the large lumbar artery, representing 99% of all the
patent arteries in these 81 patients. Three patent renal
arteries (two distal to the aortic implantation site and one
4-mm artery perfusing a nonfunctioning kidney) and 17
occluded arteries (six celiac, nine left renal, and three right
renal) were not branched.
Forty preliminary procedures (staged approach) were
performed before endovascular TAAA/PRAA repair in 33
patients (40.7%), comprising conduit creation in 20, stent-
ing of aortic branch stenoses in 10, carotid-subclavian
bypass in three, or complex procedures to create the appro-
priate anatomy to treat aortic dissection in three. All pa-
tients completed all phases of staged repairs. Two patients
underwent planned adjunctive procedures after endovascu-
lar TAAA/PRAA repair to occlude a cuff or snorkel used to
maintain spinal perfusion for a short interval after the index
procedure.
Spinal cord protection. Preoperative antihyperten-
sive medication regimens were modified (reduced) before
endovascular TAAA/PRAA repair to facilitate postopera-
tive permissive hypertension. Spinal drains were inserted in
all patients, and cerebrospinal fluid (CSF) was drained at a
constant rate of 10 mL/h during the procedure until the
last branch was inserted, when an additional 20 mL of CSF
was drained. CSF drainage was continued postoperatively
at 10 mL/h for at least 24 hours. Systemic blood pressure
was maintained at or above the patient’s usual systolic
blood pressure range. If signs or symptoms of spinal cord
ischemia developed, the systemic blood pressure was phar-
macologically elevated and CSF was drained in 10- to
20-mL increments until symptoms reversed or the onset of
headache.
Statistical analysis. Measured values are reported as
percentages or mean  standard deviation. The Student t
test and analysis of variance were used to compare the
means of continuous variables, and the Fisher exact test and
2 analysis were used to compare categoric variables. P 
.05 was considered statistically significant. Outcomes were
determined using Kaplan-Meier life-table analysis.
RESULTS
Technical. Aortic stent graft components bridging the
aneurysmal segment were inserted in all patients and
branches were inserted into all target arteries, for a technical
success rate of 100%. The mean procedure time was 6.2 
2.0 hours. Mean fluoroscopy time was 130.4  68.5 min-
utes. Mean contrast (320 mgI/dL) volume was 137.0 
81.6 mL. Estimated blood loss was 535.4  592.6 mL. whese variables improved from procedures performed early
n the study to those performed more recently (Table II).
he median length of stay was 10 days (average, 14.4 
7.1 days).
One or more vascular complications of device insertion
ccurred in 27 patients (33.3%), involving either the access
essels (13 iliofemoral, 16.0%; one brachial, 1.2%), the
orta (five, 6.2%), or the target branch artery (14, 17.3%).
arget branch artery events will be discussed subsequently.
f events involving the access arteries or the aorta, 10
equired no treatment or were treated during the index
peration, and 9 were treated at a second operation.
Survival. Three patients (3.7%) died perioperatively:
wo women (10.5%) and one man (1.6%; P  .14, Fisher
xact test). Patient 3 (PRAA) sustained hemorrhage from
erforation of a segmental renal artery branch in her solitary
idney, leading to hypotension, paraplegia, and renal fail-
re. She declined dialysis and died 11 days later. Patient 19
Crawford type III) died 7 days postoperatively of the
equelae of an inadvertent overdose of phenylephrine re-
eived on arrival in the intensive care unit. Patient 68
Crawford type IV) died at 15 days of a ruptured thoracic
ortic dissection that occurred during branched endograft
epair, despite proximal stent graft extension.
Two additional treatment-related deaths (2.5%) oc-
urred during follow-up. Patient 23 (Crawford type III)
eveloped marked thrombocytopenia, leading to hemop-
ysis, multisystem organ failure (renal failure requiring di-
lysis, paralysis, recurrent pneumonias, and respiratory fail-
re), and died at 108 days. Patient 22 (Crawford type II)
eveloped subarachnoid hemorrhage, presumably related
o the lumbar drain, followed by meningitis, hydrocepha-
us, and complications of ventriculoperitoneal shunt place-
ent, and died at 123 days.
The combined early and late-related mortality for the
ntire patient group was 6.2%, three women (15.8%) and
wo men (3.2%; P  .08, Fisher exact test). No further
eaths occurred during follow-up (mean, 21.2  17.5
onths) related to the TAAA/PRAA, the procedure, or
he branched stent graft. Freedom from TAAA/PRAA or
AAA/PRAA treatment-related death was 96% at 1 month
nd 93.4% at 6 months and thereafter (Fig 3, A). During
ollow-up, 18 additional patients (22.2%) died of a variety
f causes related to pre-existent comorbidities or the devel-
pment of new medical conditions not related to the aneu-
ysm or its treatment. All-cause mortality in this high-risk
atient group was 52% at 48 months (Fig 3, B).
Cardiopulmonary. One or more pulmonary compli-
ations developed in 12 patients (14.8%), and a periopera-
ive myocardial infarction developed in 3 (3.7%).
Neurologic. Stroke developed in four patients (4.9%),
f which one (left monoparesis) resolved by 1 month and
wo were clinically occult findings on postoperative brain
maging.
Spinal cord ischemia. Three patients (3.7%), devel-
ped permanent paralysis, two women (10.5%) and one
an (1.6%; P  .14, Fisher exact test). Onset of paralysis
as immediate in patient 69 (Crawford type II), occurred
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Volume 56, Number 1 Reilly et al 5712 hours in patient 3 (PRAA; ongoing bleeding-related
hypotension), and at 1 month in patient 23 (Crawford type
III; dialysis-related hypotension). Signs of spinal chord
ischemia developed after the procedure in 16 additional
patients (19.8%)—12 men (19.4%) and four women
(21.1%)— varying from complete paralysis to monoparesis,
14 occurred between 12 and 24 hours and two occurred
between 2 and 3 weeks. Aneurysms were pararenal in five,
Crawford type II in five, type III in one, type IV in four, and
type V TAAA in one. All patients were treated with CSF
drainage and blood pressure elevation, as indicated. All had
return of neurologic function and remained ambulatory
without symptom recurrence.
Renal function. Postoperative dialysis was initiated in
patients 3, 19, 23, and 71 (4.9%), comprising three women
(15.8%) and one man (1.6% (P  .04 Fisher exact test).
Renal insufficiency (serum creatinine rise 0.5 mg/dL)
developed in 21 patients (25.9%), comprising 5 women
(23.6%) and 16 men (25.8%). In 21 of these 25 patients,
renal branches were patent by computed tomographic an-
Fig 3. Kaplan-Meier life-tables demonstrate (A) freedom from
death related to thoracoabdominal/pararenal aortic aneurysm re-
pair (TAAA/PRAA) and (B) all-cause mortality during follow-up.
CI, Confidence interval.giography (CTA) (including three of the four new-onset iialysis patients); one renal branch was occluded in three
atients, and renal branch status was unknown in one
atient. Three of the new-onset dialysis patients died with-
ut regaining renal function. The remaining patient had
ormal renal function by 1 month postoperatively. In 15 of
he 21 patients (71.4%) who developed renal insufficiency
ot requiring dialysis, serum creatinine returned to baseline
efore discharge in 12 or after discharge in three; in the
emaining six patients, (28.6%) serum creatinine remained
levated.
During follow-up, five additional patients (6.2%) re-
uired initiation of dialysis and 8 (9.9%) developed a sus-
ained creatinine rise 0.5 mg/dL. In 8 of these 13 pa-
ients renal branches were patent by imaging or autopsy.
ne renal branch artery occluded in three patients each.
he baseline creatinine in one of these patients was 8.2
g/dL preoperatively, and expected dialysis was initiated 2
onths postoperatively, before the renal branch occluded.
he renal branch in the second patient (preoperative creat-
nine of 2.5 mg/dL and a functioning fistula preopera-
ively) occluded less than 1 month after TAAA repair,
hich precipitated his expected dialysis. In the last of these
hree patients, the contralateral renal branch remains pat-
nt, with a creatinine stable at 2 mg/dL (baseline, 1.5
g/dL). Both renal branches occluded 23 months post-
peratively in one patient, and neither could be reopened.
he final patient declined follow-up imaging, so the status
f his renal arteries is unknown; however, at 3.5 years
ostoperatively, his creatinine remains stable at 2.2mg/dL.
In summary, no patient required perioperative dialysis
ecause of renal branch occlusion. During follow-up, dial-
sis was precipitated by renal branch occlusion that oc-
urred in one patient with previously normal renal function
fter both renal branches thrombosed and in one patient
ith previously abnormal renal function after one renal
ranch thrombosed.
Major adverse events. Overall 73 of the 81 patients
90.1%) were successfully treated without occurrence of
eath, paralysis, dialysis, aneurysm rupture, or conversion
o open repair. By Kaplan-Meier life-table analysis, free-
om from these major adverse events was 94% at 1
onth, 90.8% at 6 months, and 88.4% at 24 months and
hereafter (Fig 4).
Branch patency. All planned branch insertions were
ompleted (n  306). During insertion, target branch
njury (perforation, dissection, or both) occurred in 14
atients—involving the renal artery in 11 (7.4%), celiac axis
n two (2.6%), and SMA in one (1.2%)—nonsignificant
ifferences (Table III). Seven arteries with minor injuries
equired no treatment. Seven were treated intraoperatively
ith a variety of techniques to stop bleeding or maintain
erfusion. Only one main renal artery required occlusion.
mong the 11 patients with renal artery injury, one died
patient 3), four experienced no creatinine change, three
ad a transient creatinine rise, and three had a persistent
reatinine rise, including the patient who required main
enal artery coil occlusion. During follow-up, one of the
njured arteries (celiac) occluded by 1 month postopera-
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July 201258 Reilly et altively, and a stenosis developed in one (renal) requiring
stenting 3.5 years postoperatively. Target arteries injured
during branch insertion had the same frequency of occlu-
sion or stenosis during follow-up (two of 14 [14.3%]) as
target arteries without insertion injury (13 of 291 [4.5%];
2  3.2; P  .08).
In addition to the one intraoperative main renal artery
occlusion, eight renal branches (2.6%) occluded postoper-
atively in seven patients (8.6%), four30 days. Six of these
seven patients experienced a creatinine rise, but only two
required dialysis (Fig 5). The celiac branch (0.7%) occluded
in two additional patients (2.5%). One patient was asymp-
tomatic, but one developed bleeding from gastric ulcer-
ation that resolved with medical management. No SMA
branch occluded. The difference in the occlusion rates of
the branches (0.0% SMA, 2.6% celiac axis, 6.1% renal
artery) approached significance (Table III).
During follow-up, five patients (6.2%) developed
branch stenosis (five of 306 [1.6%], involving four renal
branches, and one SMA branch; Fig 5). Four required
stenting. No branches separated, kinked, collapsed, or mi-
grated. Overall primary branch patency was 94.8%, and
primary assisted branch patency was 95.1%.
Aneurysm exclusion (endoleaks). None of the aneu-
rysms ruptured during follow-up, and there were no con-
versions to open repair. None of the components separated.
Four patients (4.9%) demonstrated aneurysm enlargement.
Two were treated successfully (one for loss of distal seal and
one to augment branch seal), one unsuccessfully (but died
at 1.5 years of cardiac disease), and one had no obvious
cause. Ten additional patients required reintervention to
optimize the initial TAAA/PRAA repair after early identi-
fication of a significant endoleak: one type IA, four type IB,
one type II, four type III (Table IV). Ten additional
patients have persistent endoleaks (eight type II, one type
III, and one uncertain type) but have not required reinter-
Fig 4. Kaplan-Meier life-table demonstrates freedom from major
adverse events (MAE; death, paralysis, dialysis, aneurysm rupture,
or conversion to open repair). CI, Confidence interval; TAAA,
thoracoabdominal aortic aneurysm.vention because the aneurysm size is stable or shrinking.Among 81 treated patients, only two developed a new
ndoleak during follow-up that was not evident on the
mmediate postoperative or 1-month CTA scan, compris-
ng one with loss of distal seal (see above) and one with
laque perforation of the endograft. Both were successfully
reated with insertion of additional components.
Reintervention. Thirty-two patients (39.5%) under-
ent 42 reinterventions (Table IV). Twenty-five early reinter-
entions (45 days of the index procedure) were most com-
only performed for access complications (n  5),
omplications of device insertion (n  5), or endoleaks (n 
). Most of the 17 late reinterventions were performed for
ndoleak (n 8), or branch stenosis/occlusion (n 5).
Freedom from reintervention declined to 66.1% by 12
onths postoperatively (Fig 6). Most reinterventions were
ndovascular procedures (64%) or involved access site re-
air (15%; Table IV).
ISCUSSION
Centers of excellence performing open TAAA repair
eport current mortality rates between 4% and 16% and
araplegia/paraparesis rates between 3.8% and 15.1%.22-28
he results in population-based studies are less encourag-
ng, with mortality rates of 19% to 32% and paraplegia/
araparesis rates of 15% to 20%.29-31 Furthermore, these
erioperative data underestimate the risk of this procedure,
ecause the 1-year related mortality is 30%.31 Recent
mprovements reflect the use of adjunctive measures to
itigate the physiologic effect of this extensive operation,
ut there is a limit to the benefit of such an approach
ecause aneurysm extent cannot be changed and patient
omorbidities cannot be eliminated. Endovascular TAAA/
RAA repair has the potential to improve these results by
liminating extensive exposure and organ ischemia and by
essening the effect of patient comorbidities.
Our perioperative mortality of 3.7% compares favor-
bly with the best results of open surgical TAAA repair
chieved in centers of excellence and exceeds that re-
orted in population-based studies. Even our combined
erioperative and late-related mortality of 6.2% com-
ares favorably with just the perioperative mortality of
onventional surgical TAAA repair. Our incidence of
ermanent paraplegia (3.7%) is also comparable to the
est results reported in open TAAA repair. Finally, our
ncidence of procedure-related dialysis (4.9% periopera-
ive and 2.5% during follow-up) is better than the results
f most single-center or population-based series of open
AAA repair. Our results also compare favorably with a
ecent series of hybrid repair (aortic debranching, fol-
owed by stent grafting), that report an average mortality
f 16.4% (range, 0%-39%), average paraplegia incidence
f 4.9% (range, 0%-14%), and average new dialysis rate of
% (range, 0%-18%).26,32-40 Overall in our series, 73 of
1 patients (90.1%) were successfully treated without the
ajor adverse clinical events of death, paralysis, dialysis,
neurysm rupture, or conversion to open repair.The validity of comparing the outcomes in this series
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bias induced by the study inclusion criteria and by the lack
of open repair and no-repair control groups. Nonetheless,
our results were obtained in a high-risk patient group, and
open repair was not an option for many.
The challenge of endovascular TAAA/PRAA repair is
preservation of branch flow, which requires appropriate
device design, accurate deployment, and positional stabil-
Table III. Branch outcomesa
Insertion
injury Patent Oc
Branch No. No. (%) No. (%) N
Celiac axis 76 2 (2.6) 74 (97.4) 2
Superior mesenteric
artery 81 1 (1.2) 81 (100) 0
Renal artery 148 11 (7.4) 139 (93.9) 9
2 5.48 5.85 5
R 0.065 0.054 0
aOne treated lumbar branch not included in the Table.
bEach patient counted only once.
cIncludes the one renal artery occluded intraoperatively.
Fig 5. Flow chart summarizes the clinical and anity. Branched stent grafts are categorized according to the mype of connection between the body of the graft and the
ranches, which can be unibody or modular. The unibody
tent graft first used for endovascular TAAA repair was
ever widely adopted because of the unavoidable complex-
ty of a device that must be precisely constructed to match
he anatomy and precisely deployed to achieve success, with
o opportunity for intraprocedural modification. In con-
rast, modular stent grafts are assembled in situ and can be
d Stenosed Stented
Stenosed or
occludedb
Injured, stenosed,
or occludedb
) No. (%) No. (%) No. (%) No. (%)
0 (0.0) 0 (0.0) 2 (2.6) 3 (3.9)
1 (1.2) 1 (1.2) 1 (1.2) 2 (2.5)
c 4 (2.7) 3 (2.0) 13 (8.8) 21 (14.2)
2.39 1.6 7.39 15.9
0.3 0.45 0.025 0
ic outcomes of the renal artery branches (RABs).clude
o. (%
(2.6)
(0.0)
(6.1)
.85
.054odified during the procedure.
JOURNAL OF VASCULAR SURGERY
July 201260 Reilly et alTable IV. Summary of all reinterventions after endovascular thoracoabdominal aortic aneurysm (TAAA) repair
Patient Indication Reintervention Intervala
Endoleak
48 Type III Palmaz stent 7
62 Type IA Additional thoracic aortic stent graft 9
26 Type III Additional thoracic aortic stent graft 17
10 Type IB Left renal branch extension 39
55 R/O Type IB Extend SMA branch (found a type II endoleak) 45
51 Type IB Right renal branch extension 50
38 Type IB Palmaz stent 105
70 Type III Additional thoracic aortic stent graft 141
15 Type III Additional aortic stent graft 346
35 Type II Coil occlusion 388
34 Type IB Occlude internal iliac branch, extend graft limb
into external iliac artery
419
37 Type III Reline SMA and celiac branches 718
21 Type IB Additional aortic stent graft 773
Branch occlusion or stenosis
29 Left renal branch stenosis Left renal branch stent 203
24 Left renal branch stenosis Left renal branch stent 234
10 SMA stenosis SMA branch angioplasty and stenting 317
7 Bilateral renal artery occlusion Attempt to reopen occluded renal branches 696
13 Left renal branch stenosis Stent insertion 1232
Insertion/access
complications
27 Compartment syndrome Fasciotomy 1
41 Left external iliac dissection Angioplasty and stenting 1
82 Left arm ischemia Left brachial embolectomy and patch angioplasty 1
68 Left femoral hematoma Common femoral arteriorrhaphy 2
82 Left arm ischemia Left brachial a interposition graft 2
68 Thoracic dissection Additional thoracic aortic stent graft 4
10 Thoracic dissection Additional thoracic aortic stent graft 5
53 Impaired perfusion left leg Left femoral endarterectomy and patch
angioplasty; popliteal embolectomy
7
54 Visceral emboli Exploratory laparotomy; oversew several
punctate small bowel lesions
7
81 Right iliofemoral thrombosis Right iliofemoral thrombectomy; femoral
endarterectomy and patch angioplasty
7
20 Thoracic false aneurysm Additional thoracic aortic stent graft 13
10 Thoracic dissection Additional thoracic aortic stent graft 35
Miscellaneous
79 Conduit infection Excision and tissue conduit replacement 0b
46 Compression of left aortoiliac
endograft limb by internal
iliac branch
Stent insertion 1
38 Spinal cord ischemia Induce type IB endoleak 1
68 Acalculous cholecystitis Percutaneous cholecystostomy 4
30 Assess endoleak Diagnostic angiogram 7
22 Hydrocephalus Insertion of ventriculoperitoneal shunt 26
23 Respiratory insufficiency Tracheostomy 26
20 Gastrointestinal bleeding Laparotomy, ligate gastroduodenal artery,
exclude duodenum
33
74 Iliobifemoral conduit
infection
Partial excision and tissue conduit replacement 54
39 Rising creatinine Diagnostic angiogram 80
46 Occlusion of left aortic
endograft limb
Femorofemoral bypass 557
31 Occlusion of left aortic
endograft limb
Femorofemoral bypass; femorotibial bypass;
fasciotomy
674
27 Mycotic femoral aneurysm Excision and tissue conduit replacement 1026
R/O, Rule out; SMA, superior mesenteric artery; TAAA, thoracoabdominal aortic aneurysm.
aInterval between endovascular thoracoabdominal aortic aneurysm repair and reintervention, in days.
bOccurred before endovascular TAAA repair.
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stent grafts—fenestration or cuff—has important conse-
quences for the behavior of the modular stent graft. A
fenestration is a reinforced hole created in the wall of the
stent graft, whereas a cuff is a short branch attached to the
stent graft. There is no intercomponent overlap (seal zone)
between a fenestration and its balloon-expanded branch,
only a nitinol reinforced fabric edge. For optimal attach-
ment, each branch of a fenestrated stent graft must radiate
straight out from the fenestration into the orifice of the
corresponding target artery. Any misalignment between
fenestration and branch orifice creates a shutter effect that
can be overcome only by distorting the stent graft, further
stressing the fragile connection with the branch. Additional
stress on this tenuous connection results from the transaxial
orientation of the balloon-expanded branch, which rarely
matches the orientation of the target artery.
A caudally directed cuff is a short branch of the stent
graft with its proximal opening in the stent graft lumen and
its distal opening in the aneurysm lumen (Fig 2). The
length of the cuff provides a true seal zone for the branch
inserted through it, which in our technique consists of a
self-expanding covered stent lined by a vascular Wallstent.
This cuffed branch structure is very stable: we observed no
migration of the branches or the main stent graft and no
component separation, branch kinking or collapse, or stent
fracture. The caudally directed cuff technique is also forgiv-
ing, allowing successful branch deployment, despite vary-
ing degrees of stent graft malposition or malorientation. As
long as the orifice of the target artery is caudal to the end of
the cuff and within a 90° radial arc of the cuff (45° to
45°), the branch can be successfully deployed.19 This
adaptability is important, because precise positioning of the
aortic stent graft components in these long, large, and
tortuous TAAA/PRAA cannot be assured.
Our primary branch patency of 95% is certainly com-
petitive with the outcomes reported in a series of hybrid
Fig 6. Kaplan-Meier life table demonstrates reintervention dur-
ing follow-up.CI, Confidence interval; TAAA, thoracoabdominal
aortic aneurysm.TAAA/PRAA repair, where branch occlusion rates average W1% (range, 2%-19%).26,32-40 Comparable branch patency
ata after open TAAA repair are not available. Although the
verall patency of the visceral branches in this series is good,
enal branch insertion and durability pose the greatest
echnical challenge of this treatment approach. Renal artery
njury during insertion, and occlusion or the development
f stenosis in a renal branch during follow-up, occurred
ignificantly more often than in the celiac or SMA (Table
II).
Compared with the celiac and SMA, the native renal
rteries are smaller in caliber, shorter, more mobile, and
ore tortuous. When the renal artery diameter is 5 mm,
ranches early (further reducing the caliber beyond the
ranch point), is tortuous in the anteroposterior and
raniocaudal planes, or has a stenotic orifice, there is an
ncreased risk of injury during branch insertion and an
ncreased risk of subsequent branch failure. This risk is
ompounded by aortic tortuosity, a large empty aneurysm,
r prior open aortic repair.
Placing a self-expanding stent into the renal artery first
ay permit subsequent successful covered stent insertion
hrough challenging angulation, tortuosity, or stenosis.
evelopment of a covered stent and delivery system specific
o the renal artery might also reduce the incidence of
eployment complications. Extending the lining stent into
he renal artery a few millimeters beyond the end of the
overed stent branch may prevent kinking of the renal
rtery over the end of covered stent and avoid later throm-
osis. Although the renal branches may be the Achilles’
eel of this technique, only two patients in our series
xperienced clinically significant sequelae of branch failure
dialysis). Challenging renal artery anatomy may compli-
ate branch insertion and threaten patency but is not an
bsolute contraindication to endovascular TAAA repair,
hich preserves treatment options for patients who other-
ise would have none.
Our reintervention rate of 39.5% is high compared with
verage reintervention rates of 15% after hybrid TAAA/
RAA repair (range, 6%-31%)26,32-40 and the 24% reinter-
ention rate reported by Conrad et al22 after open TAAA
epair. This reflects the learning curve of these complex
rocedures, but more important, reflects that we do not
erform completion angiography. This approach increases
he possibility that the first CTA will occasionally identify
ndings requiring reintervention. The effect of these rein-
erventions seems relatively limited, because all-cause mor-
ality was identical in the patients who required reinterven-
ion (28.1%) and those who did not (28.6%). That 60%
f these reinterventions (25 of 42) were endovascular pro-
edures, and an additional 15% involved treatment of the
ccess site, likely mitigates the effect (Table IV). In com-
arison, all the reinterventions after open TAAA repair are
pen procedures and reinterventions after hybrid repair are
mixture.
The versatility and stability of the caudally directed cuff
echnique allowed us to standardize stent graft design and
mplantation technique during the first phase of this study.
e believe that this process of standardization contributed
O
O
R
1
1
1
1
1
1
1
1
1
1
2
2
JOURNAL OF VASCULAR SURGERY
July 201262 Reilly et alto reproducible success, as reflected in the reduction in
operative time, contrast dose, and estimated blood loss
from the first third of this patient group to the middle third
(Table II). The last third of patients treated in this series
hadmore complex anatomy, resulting in an increased use of
the staged approach to create the anatomy needed for
endovascular TAAA repair as well as an increase in fluoros-
copy time, contrast volume, operative time, and estimated
blood loss during the index procedure, compared with
patients treated in the middle third of the series (Table II).
Early in this study, we constructed conduits and per-
formed endovascular TAAA/PRAA repair under the same
anesthetic. However, we observed the longer procedures
and anticoagulation-induced continuous bleeding from the
open operative fields frequently produced some degree of
hemodynamic instability by the time we excluded the an-
eurysm (as well as intercostal and lumbar artery) flow. So
we began to stage conduit creation and subsequently all
ancillary procedures. We believe reducing the risk of hemo-
dynamic instability at the point of aneurysm exclusion by
limiting blood loss and shortening the anesthetic may be an
important factor in our low spinal chord ischemia inci-
dence.
Outcomes in women in this series tended to be worse
than in men. Although statistical significance was not
reached in all measured outcome variables, likely due to the
low event rate and small number of enrolled women, 10.6%
of women died and 10.6% were permanently paralyzed in
comparison with 1.6% of men who died and 1.6% who were
permanently paralyzed (P  .05, Fisher’s exact). The fre-
quency of initiating perioperative dialysis was significantly
greater in women (15.8%) than in men (1.6%) (P  .04,
Fisher exact). The explanation for these differences is not
clear and requires further study.
CONCLUSIONS
Total endovascular repair of TAAA and PRAA has
advanced rapidly. Using only multibranched stent grafts
with caudally directed cuffs and a uniform operative tech-
nique, we were able to successfully treat 90% of patients
without procedure-related death, paralysis, dialysis, aneu-
rysm rupture, or conversion to open surgery. There are still
challenges to endovascular TAAA/PRAA repair, including
renal branch insertion and durability, results in women,
anatomic limitations, issues of access to devices, and dis-
semination of appropriate skills. Nonetheless, these results
support a transition from open surgical repair and hybrid
repair to total endovascular repair for all patients with
suitable thoracoabdominal and pararenal aortic aneurysms.
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Dr William J. Quinones-Baldrich (Los Angeles, Calif). I
congratulate Dr Riley and her co-investigators for their pioneer
work toward the development of a total endovascular solution for
treatment of patients with thoracoabdominal aortic aneurysms.
This is a unique series of 81 patients treated in a relatively stan-
dardized fashion with an endovascular branched graft with cuffs
placed above the origin of the visceral arteries and completed with
covered stents for revascularization of the celiac superior mesen-
teric and renal branches. Approximately 60% of the devices were
custom-made and the remainder had a consistent cuff position
considered a “standard” device. Overall, operative mortality was
6.2%, which is similar to mortality associated with open thoraco-
abdominal aneurysm repair. Cumulative survival, however, was
70% at 2 years and only 50% at 4 years, which leads to my first
question: Considering that almost 40% of patients required some
type of reintervention within the first year, was there any difference
between the cumulative survival of patients requiring reinterven-
tion versus those that did not? We all tend to minimize the impact
of additional interventions in this often elderly group of patients
and therefore I believe it is important to understand the potential
impact of additional procedures.
Approximately half of the patients were type IV thoracoab-
dominal or pararenal aneurysms and the remainder were type II,
III or V. There was an incidence of spinal cord ischemia in the
entire series of 24% with permanent paraplegia occurring in three
patients. How many patients with type IV or pararenal aneurysms
developed spinal cord ischemia? Most of these events occurred
within 24 hours of the procedure with only two occurring late, at
two or three weeks of discharge. Neurologic function improved in
most of these patients with appropriate treatment using cerebro-f them? Do any of them require an assistive device? I noticed that
our protocol for spinal fluid drainage is to drain 10cc/hr. Many of
s prefer to monitor pressure regardless of the amount of fluid
rained, maintaining an intraspinal pressure of 10 cm/H20. After
ll, it is the intraspinal pressure that we are trying to control to
romote spinal cord blood flow.Do you think this may have had an
nfluence on this high incidence of spinal cord ischemia? Have you
ade any changes to reduce this relatively high incidence of spinal
ord ischemia?
Branch graft patency overall was excellent. There was, how-
ver, a significant incidence of renal dysfunction with approxi-
ately 8% of the entire series requiring permanent dialysis. Some of
hese were associated with branch occlusion, although in others
he grafts remain patent. In your conclusions, you expressed the
eed for further technological improvements for renal branch
rafts. Can you share with us those improvements that you think
re needed? I have to assume that these patients were selected from
larger cohort evaluated at your institution for treatment of
horacoabdominal aortic pathology. How many patients were
urned down for this procedure and how were they treated? What
s your current selection criterion for endovascular treatment of a
horacoabdominal aneurysm?
Finally, it is important to recognize that this is an evolving
echnology. The UCSF group and others have been working on
he development of an endovascular graft for repair of thoracoab-
ominal aneurysms for several years. This is an enormous invest-
ent in time and money and any company involved in this effort
ill try to recover their investment. The number of patients for
hich this technology will be applicable is certainly much smaller
han those with abdominal aortic aneurysms. In the current envi-
onment, most hospitals barely cover the cost associated with
ndovascular abdominal aortic aneurysm repair due to device cost.
t
p
v
o
i
e
o
(
(
c
w
f
i
T
h
e
t
t
a
i
t
l
c
o
r
B
S
t
m
q
JOURNAL OF VASCULAR SURGERY
July 201264 Reilly et alFrom an economic standpoint, could you speculate as to the
financial impact that the commercial availability of a branched or
fenestrated graft will have in the cost of caring for patients with
thoracoabdominal aortic pathology? Can we afford this?
Once again, I congratulate you and your group for the excel-
lent contributions that you have made and continue to make in
endovascular technology. I thank you for providing me a copy of
the manuscript and your presentation well in advance of the
meeting. I thank the Society for the opportunity to discuss this
important study.
Dr Linda M. Reilly. Thank you, Dr Quinones, for the
opportunity your questions provide to present yet another paper.
The cumulative survival of patients who required reintervention
(71.9%) was the same as the cumulative survival of patients who did
not require reintervention (71.4%). We attribute this apparent lack of
impact of reintervention to the fact that 60% of these reinterventions
were endovascular procedures and an additional 15% involved only
involved treatment of an access site problem.
The three patients with permanent paralysis had one pararenal
aneurysm, one Crawford type II, and one type III aneurysm. The
distribution of aneurysm type among the 16 patients who devel-
oped transient symptoms of spinal cord ischemia was Crawford
type II in five, type III in one, type IV in four, type V in one, and
pararenal in five. The overall rate and impact of breakdown by
aneurysm type makes it impossible to establish or refute any
correlation. Recovery to independent ambulation occurred in all of
these 16. When we began this study, we monitored CSF pressure
and drained CSF fluid to maintain a target CSF pressure. As we
accumulated experience, we concluded that it made more sense to
drain CSF to reach an effect rather than to reach an arbitrarily
determined measurement. We cannot exclude the possibility that
draining CSF at a higher rate might have reduced the incidence of
the transient SCI symptoms.We do not really have the ideal devices for the renal arteries.
These arteries are smaller, more tortuous and more mobile than
p
fhe visceral branches, making cannulation, branch insertion, de-
loyment, and durability a greater challenge. We think that ad-
ances in wires, sheaths, and covered stents specific to these aspects
f renal artery anatomy might help reduce the rate of insertion
njury and late branch failure.
It is difficult to establish an accurate denominator of those
valuated for this procedure.We did eliminate 29 screened patients
n the basis of anatomy, most often involving the access arteries
too small with no option to construct a conduit), the renal arteries
too small or multiple), or the visceral arteries (aneurysmal or early
ritical branches). I cannot tell you how these excluded patients
ere treated, since many of them return to their referring surgeons
or treatment, or in many cases, continued monitoring without
ntervention. We believe that our results support endovascular
AAA/PRAA repair for any patient who is an anatomic candidate;
owever, since we are still treating patients as part of the study,
nrolled patients must still meet the published inclusion criteria for
he study.
The question of whether or not we, that is society, can afford
his type of treatment is important. At the moment, the branched
ortic component is provided at the same cost as a standard
nfrarenal aortic device, but it is unlikely to remain that way when
hese devices are on the market. The cost of each branch and its
ining stent is additional. The amount of time spent in an intensive
are setting is less than with open TAAA repair as the overall length
f stay. As is common with other endovascular techniques, the
educed cost of care will not offset the increased cost of the devices.
ut, I suspect that most open TAAA operations also lose money.
o the question is really broader: does society want to pay for the
reatment of thoracoabdominal aortic aneurysms, and if so, how
uch loss is reasonable? An important part of the answer to that
uestion may be the rapidity of recovery and the quality of life the
atient achieves after treatment, which is really what one is buying
or the cost.
